ThePrintPod: Tax doctors on research grants by drugmakers, says govt panel reviewing pharma marketing practices| Listen on Anghami

Yesterday

NationalInterest: RSS chief Mohan Bhagwat draws the line at 75. India’s politics stares at the Modi Exception

Rashtriya Swayamsevak Sangh (RSS) chief (Sarsanghachalak) Mohan Bhagwat said that once they attain the age of 75, leaders should think of retiring and yield to younger colleagues. But, in the Bharatiya Janata Party (BJP), and particularly the BJP-RSS relations, there will always ... Show More

12m 58s

Jul 11

CutTheClutter: Indo-US nuclear deal:Buried anti-Americanism, ended India's nuclear apartheid & why it still matters

Twenty years ago, a week from now, India signed a nuclear deal with the US that redefined its foreign policy, and caused a split in the Indian political sphere. The deal was a landmark moment in terms of access to technology, but also raised uncomfortable questions about liabilit ... Show More

20m 54s

Jul 11

ThePrintAM:WHAT HAS NSA DOVAL SAID ON OP SINDOOR?

WHAT HAS NSA DOVAL SAID ON OP SINDOOR? ----more---- https://theprint.in/defence/show-me-one-photo-of-any-damage-in-india-nsa-ajit-doval-dares-foreign-media-on-op-sindoor/2686905/

4m 12s

Aug 2020

Georgia State Representative David Knight & GPhA Greg Reybold | PBM Reform Podcast Series

Georgia Gov. Brian Kemp (R) has signed three innovative PBM reform bills into law. HB 946 and SB 313 require the reporting of drugs paid 10 percent above and 10 percent below National Average Drug Acquisition Cost every four months, prohibit PBMs from tying a pharmacy’s drug reim ... Show More

49m 50s

Sep 2023

Why One Drug Company Held Back a Better Drug

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.Rebecca Robbins, who co ... Show More

35m 38s

Jan 2020

The pharmacists fighting high drug prices

If you had a rare disease and the only drug that could help you suddenly shot up in price how would you feel? What if your health service or insurer decided it was too expensive and they wouldn’t fund it any more? This is the problem facing some patients in the Netherlands.In ord ... Show More

23m 40s

Aug 2016

Koons on Pfizer Agreeing to Buy Medivation (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Cynthia Koons \u0010Health Care Reporter \u0010Bloomberg Editorial \u0010on Pfizer beating out rivals to buy biopharmaceutical company, Medivation, and its blockbuster cancer drug for $14 billi ... Show More

7m 19s

Nov 2023

How to Buy DRUGS: The Finances of the Pharmaceutical Industry with Hitha Palepu

On this week's episode of Networth and Chill, I'm joined by author and CEO of Rhoshan Pharmaceuticals, Hitha Palepu to talk drug prices and the pharmaceutical industry. Drug prices are a hot topic these days, and it seems like the cost of life saving medications like insulin and ... Show More

41m 53s

Feb 2021

Cannabis industry expected to hit $41 Billion by 2025

Ireland-based biopharmaceutical company Jazz Pharmaceuticals buys the biggest acquisition in the cannabis industry to date after agreeing to buy GW Pharmaceuticals for $7.2 billion last week. Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio.c ... Show More

33m 55s

Aug 2023

A Major Overhaul of Prescription Drug Prices

A year ago, Congress overhauled the way drugs for older Americans get paid for, by giving Medicare the power to bargain with drug makers over prices in the biggest change to health care for more than a decade. This week, the Biden administration began its implementation.Sheryl Ga ... Show More

32m 45s

Sep 2023

AI-Powered Pharmacy Care: Revolutionizing Patient Support and Adherence | Digital Therapeutalks

Imagine being able to use A.I. text interaction with a patient who recently began to use a continuous glucose monitoring device and was able to ask questions and recieve contexual human-like responoses which were documented and tied into the medical records for pharmacist and phy ... Show More

35m 37s

Oct 2021

Sick Money (Pt 1): Exposing the drug companies' price gouging tactics

In the first of two episodes this week, we're taking a deep dive into the pharmaceutical industry. How much does the medication you take actually cost? What if a company came along and bought the rights to a particular drug and started charging double, triple, or even 10,000 time ... Show More

29m 31s

ThePrintPod: Tax doctors on research gra...